These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24854563)

  • 1. [Advances on driver oncogenes of squamous cell lung cancer].
    Hong W; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2014 May; 17(5):433-6. PubMed ID: 24854563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances on driver oncogenes of lung adenocarcinoma].
    Wang J; Zhang Z; Zhang S
    Zhongguo Fei Ai Za Zhi; 2013 Feb; 16(2):91-6. PubMed ID: 23425901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances on driver oncogenes of non-small cell lung cancer].
    Zhao J; Xiong J
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):42-7. PubMed ID: 25603872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
    Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
    Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ
    J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.
    Ricordel C; Lespagnol A; Llamas-Gutierrez F; de Tayrac M; Kerjouan M; Fievet A; Hamdi-Rozé H; Aliouat A; Desrues B; Mosser J; Léna H
    Clin Lung Cancer; 2018 Mar; 19(2):163-169.e4. PubMed ID: 29129434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased FGFR1 copy number in lung squamous cell carcinomas.
    Sasaki H; Shitara M; Yokota K; Hikosaka Y; Moriyama S; Yano M; Fujii Y
    Mol Med Rep; 2012 Mar; 5(3):725-8. PubMed ID: 22179561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
    Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
    Behrens C; Lin HY; Lee JJ; Raso MG; Hong WK; Wistuba II; Lotan R
    Clin Cancer Res; 2008 Oct; 14(19):6014-22. PubMed ID: 18829480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.
    Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S
    Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
    Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
    Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
    Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.
    Shi X; Wu H; Lu J; Duan H; Liu X; Liang Z
    Sci Rep; 2016 Feb; 6():22297. PubMed ID: 26923333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overexpression of OLC1 in Lung Squamous Cell Carcinoma Tissues is Associated with Poor Prognosis of Patients].
    Zhang K; Zhao G; Xiao T; Li P; Song J; Gao Y; Sun K
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):346-351. PubMed ID: 28532543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
    Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
    Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.